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Background: A rare neuro-ichthyotic disorder characterized by ichthyosis, spastic quadriplegia and intellectual
disability and caused by recessive mutations in ELOVL4, encoding elongase-4 protein has recently been described.
The objective of the study was to search for sequence variants in the gene ELOVL4 in three affected individuals of a
consanguineous Pakistani family exhibiting features of neuro-ichthyotic disorder.
Methods: Linkage in the family was searched by genotyping microsatellite markers linked to the gene ELOVL4,
mapped at chromosome 6p14.1. Exons and splice junction sites of the gene ELOVL4 were polymerase chain
reaction amplified and sequenced in an automated DNA sequencer.
Results: DNA sequence analysis revealed a novel homozygous nonsense mutation (c.78C > G; p.Tyr26*).
Conclusions: Our report further confirms the recently described ELOVL4-related neuro-ichthyosis and shows that
the neurological phenotype can be absent in some individuals.
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Elongation of Very Long chain fatty acids-4 (ELOVL4) is
a member of a large family of fatty acid elongases (ELO),
involved in biosynthesis of very long-chain fatty acid
(VLCFAs) with chain length ≥24 carbon atoms. Fatty
acid elongases add two-carbon extensions to existing fatty
acid substrates to generate longer chained fatty acids [1].
Seven members of the ELOVL family (ELOVL1-7) have
been identified in humans that differ from each other in
their substrate specificity, tissue expression and develop-
mental patterns [2-4]. These can be divided into two
major groups including ELOVL1, 3, 6 and 7, which are
suggested to be elongases of saturated and monounsatu-
rated VLCFA and ELOVL2 and 5, which are involved in
the elongation of polyunsaturated fatty acids (PUFA) [2].
It has been identified that ELOVL4 is active both in the
elongation of saturated VLCFA and in the biosynthesis of
polyunsaturated VLC-PUFA [5].* Correspondence: wahmad@qau.edu.pk
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reproduction in any medium, provided the orIt was first identified that heterozygous mutations in
the gene ELOVL4 are responsible for a dominant form of
Stargardt-like macular dystrophy (STGD3) [6]. Patients with
heterozygous ELOVL4 mutations exhibit macular degener-
ation, which is probably related to a deficiency of VLCFA-
containing lipids in the retina [7]. Recently, Aldahmesh et al.
[8] have shown recessive mutations in the gene ELOVL4
in two children causing congenital ichthyosis, along with a
profound neurological phenotype and spastic quadriplegia.
In the present study we have investigated a consanguin-
eous Pakistani family displaying an autosomal recessive
neuroichthyotic disorder. Genotyping using microsatellite
markers showed linkage of the family to the gene ELOVL4,
mapped on chromosome 6q14. Subsequently, sequence
analysis of the gene revealed a novel homozygous non-
sense mutation (p.Tyr26*).Methods
Subjects
For the study, presented here, a four generation consan-
guineous family demonstrating autosomal recessive form. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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region of Pakistan (Figure 1a). Approval of the study
was obtained from the Institutional Review Board (IRB)
of Quaid-i-Azam University, Islamabad Pakistan. Both
affected and unaffected members of the family were in-
formed about research methodology and objectives of this
study. Pedigree drawing of the family was based upon
detailed question/answer sessions from affected and elders
of the family. Affected individuals IV-1, IV-2 and IV-5
were 24, 16 and 22 years old at the time of the study. The
affected member IV-2 died recently at the age of 17 years.
Genomic DNA was extracted from peripheral blood
samples collected from three affected and three unaffected
members of the family by GenElute™ blood genomic
DNA kit (Sigma-Aldrich, St. Louis, MO, USA). A skin
biopsy was performed and the sample was fixed in 10%
formalin and embedded in paraffin. Four-μm-thick sections
were stained with hematoxylin-eosin.
Genotyping
The family was tested for linkage by genotyping microsat-
ellite markers linked to genes involved in neuro-ichthyotic
syndromes. These include Aldehyde Dehyrogenase 3A2
gene (ALDH3A2, MIM 270200) on chromosome 17p11
(D17S261, D17S1857, D17S1794, D17S805, D17S842,
D17S783, D17S1878), involved in Sjögren-Larsson Syn-Figure 1 Pedigree drawing of a consanguineous Pakistani family and
drawing of a consanguineous Pakistani family with a neuro-ichthyotic disor
Clear symbols represent unaffected individuals while filled symbols represe
individuals. Symbols with a star represent the samples that were available f
erythematous and hyperkeratotic skin on hands and feet of 18 year old aff
(f-h) Histological examination of a skin biopsy of the affected individual IV-1 s
the basal layer of epidermis and sparse lymphocytic cellular infiltrate scattered
for the study and presentation of the photographs for publication was obtaindrome (SLS), and Elongase-4 gene (ELOVL4,MIM 605512)
on chromosome 6p14.1 (D6S1659, D6S1031, D6S286,
D6S251, D6S391, D6S1609, D6S1627). Order of markers
was based on Rutgers combined linkage-physical map of
the human genome [9].
Sequencing
Standard sequence of the gene ELOVL4 was obtained
from Ensembl Genome Browser (http://asia.ensembl.
org/index.html). Primers for PCR (polymease chain re-
action) amplification of all six exons and splice junction
sites of the gene were designed using Primer3 version
0.4.0 software [10]. DNA sequencing was performed
with Big Dye Terminator v3.1 Cycle Sequencing Kit,
together with an ABI Prism 310 Genetic Analyzer
(Applera, Foster City, CA, USA). Sequence variants were
identified via Bioedit sequence alignment tool (editor
version 6.0.7, Ibis, Biosciences, CA, USA).
Results
Clinical features
All three affected individuals (IV-1, IV-2, IV-5) of the fam-
ily, presented here, showed typical features of the hereditary
ichthyosis. Skin in all the affected individuals was dry,
erythematous and hyperkeratotic with scales present on
lips, tip of the nose, ear pinna, legs, matacarpophalangealclinical features observed in affected members. (a) Pedigree
der. Circles and squares represent females and males, respectively.
nt affected individuals. Symbols with crossed lines represent deceased
or the study. (b-c) clinical features of hereditary ichthyosis with dry,
ected individual IV-1; (d-e) and 14 year old affected individuals IV-2.
howed hyperkeratosis and acanthosis of the epidermis, with edema of
in the dermis mainly around the blood vessels. Informed written consent
ed from affected and unaffected individuals and their parents.
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recently, back and neck were also affected. Intellectual
disability and spastic quadriplegia were observed only
in patient IV-2. He was born by normal vaginal delivery
at home, but develops fever accompanied by frequent
urination at 4 months of age. Profound developmental
delay and occurrence of seizures were reported, a year
after birth. Seizures were occurring very frequently mostly
at twenty minutes time interval. Severe hypertonia devel-
oped in the upper and lower extremities in this individual.
Bones and muscles appeared extremely weak. Speech and
hearing were abnormal. He remained bed ridden until he
died. Oral examination showed leukoplakia with white
patches appeared on tongue. Significant dental erosion
involving second incisor and canine were observed.
Fundus examination of four individuals (IV-1, IV-5,
III-2, III-3) was carried out at Shifa Hospital Islamabad
(Figure 2). Fundus examination of two affected individuals
(IV-1, IV-5) showed no significant refractive error. How-
ever, tortuous vessels in the macular area with subtle
macular changes were noted in these two individuals. In
father (III-2) of the three affected children, the fundus
examination revealed mild degree of myopia with subtle
peripapillary changes. In mother (III-3) fundus examin-
ation was normal (III-3).
Skin biopsy of the affected individual IV-1 showed
hyperkeratosis and acanthosis of the epidermis, edema
of the basal layer of epidermis causing its disruption and
leading to the formation of sub epidermal cleft formationFigure 2 Fundus examination of four individuals including two affect
Note tortuous vessels in the macular area in the two affected individuals in(Figure 1). Sparse lymphocytic cellular infiltrate scattered
in the dermis mainly around the blood vessels was noted.
In all the three affected individuals ichthyosis was
present since birth. In cold weather, this condition turns
to more severe form which develops itching and pain in
the affected areas. Prominent ears with large pinna and
yellow pigmented nails were observed in all the affected
individuals.
Magnetic resonance imaging (MRI) and computed tom-
ography (CT) scan images of the affected individuals were
not available for the study. History of cardiac, diabetic and
immunological problems was not reported in any of the
affected individuals. Obligate heterozygous carriers in the
family were normal and were clinically indistinguishable
from genotypically normal individuals.Linkage and mutation analysis
Linkage in the family was established to microsatellite
markers linked to the gene ELOVL4 mapped on chromo-
some 6q14.1. Subsequently, sequence analysis of exon 1
of the gene ELOVL4 detected a novel homozygous non-
sense mutation involving C to G transition at nucleotide
position 78 (c.78C >G) (Figure 3a). This resulted in substi-
tution of a codon for tyrosine at amino acid position 26 to
stop-codon (p.Tyr26*). The sequence variant, identified
here, was present in the heterozygous state in the obligate
carriers of the family and was not identified in 100 normal
Pakistani individuals.ed IV-1 (a) and IV-5 (b), father III-2 (c) and mother III-3 (d).
panel a and b.
Figure 3 Sequence analysis of a homozygous nonsense mutation (c.78C > G; p.Tyr26*) in the gene ELOVL4. The upper panels (a) represent
the nucleotide sequences in the control unaffected individual, the middle panels (b) in the heterozygous carrier and the lower panels (c) in
the affected individual. Arrow indicates position of C to G transversion. (d) Schematic representation of the human ELOVL4 structural and functional
domains. Position of the recessive mutation identified here (in red) and those reported earlier (in black) are shown. TM 1-5, Transmembrane Domain
1-5, Diiron-oxo binding domain, Dilysine motif.
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In the present investigation, we have reported clinical
and molecular analysis of a consanguineous Pakistani
family presenting clinical manifestations of a neuro-ich-
thyotic syndrome. Intra-familial phenotypic variability
was observed among affected individuals of the family.
Characteristic features of ichthyosis affecting different
parts of the body were observed in all three affected in-
dividuals. However, other features including intellectual
disability, hypertonia and spastic quadriplegia linked to
the neuro-ichthyotic syndrome were observed only in
one affected individual of the family. This individual died
recently. Similar features were reported in two individuals
with a neuro-ichthyotic syndrome by Aldahmesh et al. [8].
Clinical features including leukoplakia, prominent ears
with large pinna and yellow pigmented nails, observed
with variable severity, in affected individuals of the present
family were not reported earlier. Other features like inguinalhernias, small testicular size, and microcephaly reported
by Aldahmesh et al. [8], were not observed in affected
members of our family.
Genotyping using microsatellite marker established link-
age in the family to the gene ELOVL4 on chromosome
6p14.1. Sequence analysis of the gene revealed a novel
homozygous nonsense mutation (p.Tyr26*) in all three
affected individuals. To date, two recessive mutations
(p.Arg216*, p.Ile230Metfs*22) causing a neuro-ichthyotic
syndrome [8] and three heterozygous mutations (p.As
n264Thrfs*10, p.Asn264Leufs*9, p.Tyr270*) causing
Stargardt-like macular degeneration [6,11-13] have been
reported in the gene ELOVL4.
The gene ELOVL4, containing six coding exons, spans
32.7 kb of genomic DNA and encode 314 amino acids
protein. The ELOVL4 contains five membrane-spanning
domains, a histidine cluster motif (HXXHH) involved in
enzymatic activity, and endoplasmic reticulum retention
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C-terminus (Figure 3b). All the previous mutations
reported in the gene ELOVL4 were clustered in the C
terminus of the protein. The novel mutation (p.Tyr26*),
identified in the present study, is the only mutation
located at N-terminus of the protein. This mutation is
predicted to result in loss of function of the ELOVL4
protein either through nonsense mediated mRNA decay
or production of a truncated protein. In the latter case,
the truncated protein product lacks five transmemrane
domains, a histidine cluster and a dilysine-motif. It is highly
likely that the mutant ELOVL4 protein carrying the
nonsense mutation (p.Tyr26*) may lack the elongase
activity required for synthesis of very-long-chain fatty
acids (VLCFAs) in skin and brain, and results in the
abnormal localization of the protein as well.Conclusion
In this study we have reported only the third recessive
mutation in the gene ELOVL4 causing neuro-ichthyotic
syndrome. Interestingly, analysis revealed the same mu-
tation resulted in appearance of neurological phenotype
only in one of the three affected individuals of the same
family. As ELOVL4 is involved in the elongation of C26
to C28 VLCFAs, that are important components of retinal,
skin and brain phospholipids and sphingolipids [1,2], any
change in the structure and stability of ELOVL4 protein
may alter this pathway of VLCFAs biosynthesis. One of
the possible factors contributing towards phenotypic
variability, observed in the three affected individuals, is
alternative use of at least one of the eleven in-frame
ATG codons downstream of the mutation site.
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